ABCLVSPRME• 12 Months (Normalized)
ABCL vs PRME (AbCellera Biologics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Sep, 15, 2025 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABCL Performance $11.41
+162.3%
AbCellera Biologics Inc.
Normalized Baseline0.00%
PRME Performance $3.14
-21.7%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin ABCL LEADS
+184%
ABCL outperforming by 184.00%
ABCLPRME
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABCL PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ABCL Price | ABCL Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $11.41 | +162.30% | $3.14 | -21.70% | +184.00% |
| Sep 14, 2026 | $11.17 | +156.78% | $3.18 | -20.70% | +177.48% |
| Sep 11, 2026 | $10.89 | +150.34% | $3.13 | -21.95% | +172.29% |
| Sep 10, 2026 | $10.46 | +140.46% | $3.35 | -16.46% | +156.92% |
| Sep 09, 2026 | $11.05 | +154.02% | $3.47 | -13.47% | +167.49% |
| Sep 08, 2026 | $11.44 | +162.99% | $3.56 | -11.22% | +174.21% |
| Sep 04, 2026 | $11.43 | +162.76% | $3.70 | -7.73% | +170.49% |
| Sep 03, 2026 | $11.57 | +165.98% | $3.71 | -7.48% | +173.46% |
| Sep 02, 2026 | $11.36 | +161.15% | $3.67 | -8.48% | +169.63% |
| Sep 01, 2026 | $11.28 | +159.31% | $3.57 | -10.97% | +170.28% |
| Aug 31, 2026 | $11.48 | +163.91% | $3.59 | -10.47% | +174.38% |
| Aug 28, 2026 | $11.35 | +160.92% | $3.61 | -9.98% | +170.90% |
| Aug 27, 2026 | $12.40 | +185.06% | $3.64 | -9.23% | +194.29% |
| Aug 26, 2026 | $12.24 | +181.38% | $3.58 | -10.72% | +192.10% |
| Aug 25, 2026 | $12.50 | +187.36% | $3.71 | -7.48% | +194.84% |
Page 1 of 17